Patent classifications
C12N2795/10311
<i>Lactococcus garvieae </i>bacteriophage Lac-GAP-3 and use thereof in inhibiting proliferation of <i>Lactococcus garvieae </i>bacteria
The present invention relates to Siphoviridae bacteriophage Lac-GAP-3 (Accession Number KCTC 12816BP) having the ability to specifically kill Lactococcus garvieae bacteria and a genome represented by SEQ ID NO: 1 and isolated from nature, and a method for prevention and treatment of Lactococcus garvieae bacterial infection by using a composition containing the same bacteriophage as an effective ingredient.
NOVEL LACTOCOCCUSGARVIEAE BACTERIOPHAGE LAC-GAP-3 AND USE THEREOF IN INHIBITING PROLIFERATION OF LACTOCOCCUSGARVIEAE BACTERIA
The present invention relates to Siphoviridae bacteriophage Lac-GAP-3 (Accession Number KCTC 12816BP) having the ability to specifically kill Lactococcusgarvieae bacteria and a genome represented by SEQ ID NO: 1 and isolated from nature, and a method for prevention and treatment of Lactococcusgarvieae bacterial infection by using a composition containing the same bacteriophage as an effective ingredient.